Your browser doesn't support javascript.
loading
Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis.
Novak, Frederik; Nilsson, Anna Christine; Nielsen, Christian; Holm, Dorte K; Østergaard, Kamilla; Bystrup, Anna; Byg, Keld-Erik; Johansen, Isik S; Mittl, Kristen; Rowles, William; Mcpolin, Kira; Spencer, Collin; Sagan, Sharon; Gerungan, Chloe; Wilson, Michael R; Zamvil, Scott S; Bove, Riley; Sabatino, Joseph J; Sejbaek, Tobias.
Afiliación
  • Novak F; Department of Neurology, Hospital Southwest Jutland, University Hospital of Southern Denmark, Esbjerg, Denmark; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Nilsson AC; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Nielsen C; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Holm DK; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Østergaard K; Department of Neurology, Nordsjællands Hospital, Hillerød, Denmark.
  • Bystrup A; Department of Neurology, Hospitalsenhed Midt, Viborg, Denmark.
  • Byg KE; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
  • Johansen IS; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Mittl K; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Rowles W; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Mcpolin K; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Spencer C; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Sagan S; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Gerungan C; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Wilson MR; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Zamvil SS; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Bove R; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Sabatino JJ; Weill Institute for Neurosciences, Department of Neurology, University California San Francisco, San Francisco, United States.
  • Sejbaek T; Department of Neurology, Hospital Southwest Jutland, University Hospital of Southern Denmark, Esbjerg, Denmark; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark. Electronic address: tobias.sejbaek@rsyd.dk.
Mult Scler Relat Disord ; 56: 103251, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34571415
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca